Showing results (81-90 of 118) with videos related to
Sort By:
Pageof 12
Journal of Neurointerventional Surgery|January 7, 2015
Transradial access in acute ischemic stroke interventionDiogo C Haussen, Raul G Nogueira, Keith G DeSousa, et al.Journal of Neurointerventional Surgery|September 19, 2014
Posterior communicating and vertebral artery configuration and outcome in endovascular treatment of acute basilar artery occlusionDiogo C Haussen, Sushrut S Dharmadhikari, Brian Snelling, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 8, 2022
Cohort study on the differential expression of inflammatory and angiogenic factors in thrombi, cerebral and peripheral plasma following acute large vessel occlusion strokeXavier O Scott, Stephanie H Chen, Roey Hadad, et al.Bioconjugate Chemistry|November 27, 2014
Simple radiometric method for accurately quantitating epitope densities of hapten-protein conjugates with sulfhydryl linkagesEric C Peterson, Michael D Hambuchen, Rachel L Tawney, et al.Frontiers in Pharmacology|May 25, 2023
Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in ratsVenumadhav Janganati, Paloma Salazar, Brian J Parks, et al.Journal of Neurointerventional Surgery|January 22, 2020
Treatment and diagnosis of cerebral aneurysms in the post-International Subarachnoid Aneurysm Trial (ISAT) era: trends and outcomesEvan Luther, David J McCarthy, Marie-Christine Brunet, et al.Expert Review of Neurotherapeutics|July 25, 2016
Cavernous carotid aneurysms: a new treatment paradigm in the era of flow diversionDaniel M S Raper, Dale Ding, Eric C Peterson, et al.Journal of Medicinal Chemistry|June 21, 2011
Synthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccinesF Ivy Carroll, Bruce E Blough, Ramakrishna R Pidaparthi, et al.The Journal of Pharmacology and Experimental Therapeutics|April 5, 2020
The Development and Characterization of an scFv-Fc Fusion-Based Gene Therapy to Reduce the Psychostimulant Effects of Methamphetamine AbuseCharles E Hay, Laura E Ewing, Michael D Hambuchen, et al.Journal of Medicinal Chemistry|November 3, 2009
The synthesis of haptens and their use for the development of monoclonal antibodies for treating methamphetamine abuseF Ivy Carroll, Philip Abraham, Paul K Gong, et al.Pageof 12